Failure of a first regimen of monotherapy to control the newly diagnosed epilepsies. What to do next?

Andrew T., Milinis K., Baker G., Galimberti C.A.:Self reported adverse effects of mono and polytherapy for epilepsy. Seizure, 2012, 21: 610–613.10.1016/j.seizure.2012.06.013Search in Google Scholar

Brodie M.J., Barry S.J.E., Bamagous G.A., Norrie J.D., Kwan P.:Patterns of treatment response in newly diagnosed epilepsy. Neurology, 2012, 78: 1548–1554.10.1212/WNL.0b013e3182563b19Search in Google Scholar

Canevini M.P., De Sarro G., Galimberti C.A., Gatti G., Licchetta L., Malerba A. et al.:on behalf of the SOPHIE Study Group.: Relationship between adverse effects of antiepileptics drugs, number of coprescribed drugs, and drug load in a large cohort of consecutive patients with drug-refractory epilepsy. Epilepsia, 2010, 51: 797–804.Search in Google Scholar

Deckers C.L.P.:Place of politherapy in the early treatment of epilepsy. CNS Drugs, 2002, 16: 155–163.10.2165/00023210-200216030-00002Search in Google Scholar

Deckers C.L.P., Hekster Y.A., Keyser A., Meinardi H., Renier W.O.:Monotherapy versus polytherapy for epilepsy: a multicenter double-blind randomized study. Epilepsia, 2001, 42: 1387–1394.10.1046/j.1528-1157.2001.30800.xSearch in Google Scholar

Garnett W.R., St. Louis E.K., Henry T.R., Bramley T.:Transitional polytherapy: tricks of the trade for monotherapy to monotherapy AED conversation. Cur. Neuropharmacol., 2009, 7: 83–95.10.2174/157015909788848884Search in Google Scholar

Glauser T., Ben-Menachem E., Bourgeois B., Cnaan A., Guerreiro C., Kälviäinen R., Mattson R., French J.A., Perucca E., Tomsom T. for the ILAE Subcommission on AED Guidelines.:Updated ILAE evidence review of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes. Epilepsia, 2013, 54: 551–563.10.1111/epi.12074Search in Google Scholar

Kwan P., Brodie M.J.:Early identification of refractory epilepsy. N. Engl. J. Med., 2000a, 342: 314–319.10.1056/NEJM200002033420503Search in Google Scholar

Kwan P., Brodie M.J.:Epilepsy after the first drug fails: substitution or add-on? Seizure, 2000b, 9: 464–468.10.1053/seiz.2000.0442Search in Google Scholar

Kwan P., Brodie M.J.:Combination therapy in epilepsy: when and what to use. Drugs, 2006, 66: 1817–1829.10.2165/00003495-200666140-00004Search in Google Scholar

Marson A.G., Al-Kharusi A.M., Alwaidh M., Appleton R., Baker G.A., Chadwick D.W. et al., on behalf of the SANAD Study group:The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial. Lancet, 2007a, 369: 1016–1026.10.1016/S0140-6736(07)60461-9Search in Google Scholar

Marson A.G., Al-Kharusi A.M., Alwaidh M., Appleton R., Baker G.A., Chadwick D.W. et al., on behalf of the SANAD Study group:The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial. Lancet, 2007b, 369: 1000–1015.10.1016/S0140-6736(07)60460-7Search in Google Scholar

Mattson R.H., Cramer J.A., Collins J.F.:Comparision of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonic-clonic seizures. N. Engl. J. Med., 1985, 313: 145–151.10.1056/NEJM198507183130303Search in Google Scholar

Millul A., Iudice A., Adami M., Porzio R., Mattana F., Beghi E.:Alternative monotherapy or add-on therapy in patients with epilepsy whose seizures do not respond to the first monotherapy: an Italian multicenter prospective observational study. Epilepsy Behav., 2013, 28: 494–500.10.1016/j.yebeh.2013.05.038Search in Google Scholar

National Institute for Health and Clinical Excellence:The epilepsies: the diagnosis and management of the epilepsies in adults and children in primary and secondary care. 2012 (www. nice.org.uk/cg137)Search in Google Scholar

Perucca E., Tomson T.:The pharmacological treatment of epilepsy in adults. Lancet Neurol., 2011, 10: 446–456.10.1016/S1474-4422(11)70047-3Search in Google Scholar

Schmidt D.:Reduction of two-drug therapy in intractable epilepsy. Epilepsia, 1983, 24: 368–376.10.1111/j.1528-1157.1983.tb04900.x6406214Search in Google Scholar

Shorvon S.D., Chadwick D., Galbraith A.W., Reynolds E.H.:One drug for epilepsy. Br. Med. J., 1978, 342: 314–319.Search in Google Scholar

Stephen L.J., Brodie M.J.:Antiepileptic drug monotherapy versus polytherapy: pursuing seizure freedom and tolerability in adults. Curr. Opin. Neurol., 2012, 25:164–172.10.1097/WCO.0b013e328350ba6822322411Search in Google Scholar

Smith B.J., St. Louis E.K., Stern J.M., Green C., Bramley T.:Concerns with AED conversation: comparison of patient and physician perspectives. Curr. Neuropharmacol., 2009, 7: 120–124.10.2174/157015909788848947273000319949570Search in Google Scholar